Year : 2022
Bacopa monnieri for disorders affecting brain: Current perspectives
Cite this Research Publication :
Adithya V, S Sathianarayanan, Anju Elizabath, Prashant Sadanandan, KV Athira, Baskar V. Bacopa monnieri for disorders affecting brain: Current perspectives. Current topics in medicinal chemistry, 2022. doi: 10.2174/1568026622666220119111538
Publisher : Current topics in medicinal chemistry
Year : 2022
Exploiting the preferential phagocytic uptake of nanoparticle-antigen conjugates for the effective treatment of autoimmunity
Cite this Research Publication :
Prashant Sadanandan, Natalie P, Guizhi S, Anusha A, Siddaramana G, Arsha L, Satheesh K, Sreeranjini P, S V Nair, K N Menon, Claude Bernard, Manzoor K. Exploiting the preferential phagocytic uptake of nanoparticle-antigen conjugates for the effective treatment of autoimmunity. Nanomedicine: Nanotechnology, Biology and Medicine, 2022, 40, 102481. doi: 10.1016/j.nano.2021.102481
Publisher : Nanomedicine: Nanotechnology, Biology and Medicine
Year : 2021
Repurposing Vorinostat for the Treatment of Disorders Affecting Brain
Cite this Research Publication : Athira, K.V., Sadanandan, P., Chakravarty, S., "Repurposing Vorinostat for the Treatment of Disorders Affecting Brain," NeuroMolecular Medicine, 2021, 23(4), pp. 449-465, doi: 10.1007/s12017-021-08660-4. Epub 2021 May 4.
Publisher : NeuroMolecular Medicine
Year : 2020
Evaluation of Kaempferol as AKT Dependent mTOR Regulator via Targeting FKBP-12 in Hepatocellular Carcinoma: an In silico Approach
Cite this Research Publication :
Siniprasad P, Nair B, Balasubramaniam V, Sadanandan, Prashant, Namboori P K, Nath L R. Evaluation of Kaempferol as AKT Dependent mTOR Regulator via Targeting FKBP-12 in Hepatocellular Carcinoma: An In silico Approach. Letters in Drug Design & Discovery, 2020, 17 (11), 1401-1408. doi: 10.2174/1570180817999200623115703
Publisher : Letters in Drug Design & Discovery
Year : 2016
Nanoengineered Myelin Oligodendrocyte Glycoprotein Peptides Suppressed Experimental Autoimmune Encephalomyelitis: Implications In Multiple Sclerosis Therapy
Cite this Research Publication :
Prashant Sadanandan, N Payne, G Sun, A Ashokan, Wilbin X, S G Gowd, S V Nair, K N Menon, Claude Bernard, Manzoor K. Nanoengineered myelin oligodendrocyte glycoprotein peptides suppressed experimental autoimmune encephalomyelitis: Implications in Multiple Sclerosis therapy. European Journal of Immunology, 2016, 46 (1), 316-317. doi: 10.1002/eji.201670200
Publisher : European Journal of Immunology